Adventus Ventures

Adventus Ventures is a venture capital investment firm and medical device incubator based in Irvine, California. Established in 2017, the firm focuses on the health technology sector, providing funding and support to innovative companies in this field. By leveraging its expertise in medical devices and health technology, Adventus Ventures aims to foster the development of groundbreaking solutions that improve patient care and health outcomes.

Carla-Mann Woods

COO and Board Member

4 past transactions

Temari Medical

Seed Round in 2018
Temari Medical develops cerebral aneurysm embolic protection system. The company’s product includes enfold thin film endovascular occluder which is a device that expands from a compressed state to fill the volume of the aneurysm sac and divera flow diverter stent which offers closed cell design for optimal porosity. Temari Medical is headquartered in Santa Clara, California.

Allevion Therapeutics

Seed Round in 2018
Allevion Therapeutics, Inc. develops a smart wearable device that reduces hand and leg tremor, specifically Essential Tremor (ET). The company offers Allevx Smartcuff, a lightweight wrist or ankle device delivers multimodal stimulation with novel delivery algorithm to reduce tremor. It allows patients to regain confidence and improve their quality of life by addressing ET and other movement related disorders, such as Parkinson's disease (PD) and Dystonia. It offers multi point delivery, multimodal energy, flexible cuff selection, smart therapy, intuitive connectivity, and low power design. The company was incorporated in 2017 and is headquartered in Irvine, California.

Zed Medical

Seed Round in 2018
Developing the next generation cerebral aneurysm embolic protection system providing better treatment options.

Pressao Medical

Seed Round in 2018
Pressao Medical, Inc. is a healthcare company founded in 2018 and based in Delaware, United States. The company specializes in developing a smart, non-invasive wearable device aimed at treating uncontrolled hypertension and prehypertension. This innovative device utilizes neuromodulation technology and delivers transcutaneous ultrasound therapies to help manage blood pressure effectively. Pressao Medical's solution targets individuals at risk for serious cardiovascular events, such as strokes or heart attacks, by providing a therapeutic method to relax the nervous system and maintain blood pressure within desired ranges.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.